UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029088
Receipt number R000033268
Scientific Title Effect of probiotics and/or synbiotics on intestinal environment in healthy adults.
Date of disclosure of the study information 2019/04/01
Last modified on 2019/09/06 16:23:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of probiotics and/or synbiotics on intestinal environment in healthy adults.

Acronym

Effect of probiotics and/or synbiotics on intestinal environment.

Scientific Title

Effect of probiotics and/or synbiotics on intestinal environment in healthy adults.

Scientific Title:Acronym

Effect of probiotics and/or synbiotics on intestinal environment.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the effect of bifidobacterium and/or bifidobacterium with dietary fiber on intestinal environment.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

16S rRNA gene based metagenome analysis of gut microbiome

Key secondary outcomes

Fecal short chain fatty acid concentration, fecal bifidobacteria, defecation frequency


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of drink containing high-dose bifidobacterium for 4 weeks - Washout 4 weeks.

Interventions/Control_2

Intake of drink containing low-dose bifidobacterium for 4 weeks - Washout 4 weeks.

Interventions/Control_3

Intake of drink containing bifidobacterium with dietary fiber for 4 weeks - Washout 4 weeks.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Subjects whose defecation frequency is more than five times per week.

Key exclusion criteria

1. Subjects regularly use intestinal drugs and laxatives (including strong laxatives).
2. Subjects habitually consume higher amount of alcohol.
3. Subjects who can't stop intake food containing bifidobacteria, and/or enhanced with oligosaccharide, dietary fiber during this study.
4. Subjects who have serious diseases requiring an urgent treatment, or who accept severe complication.
5. Subjects who have a medical history of diseases or surgeries affecting digestion, absorption and bowel movement.
6. Subjects who have allergy to test food.
7. Subjects who is pregnant or willing to be pregnant or breast-feeding during this study.
8. Subjects who are participated in other clinical trials that intake/apply any of food, drug, and cosmetics.

Target sample size

45


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Mawatari

Organization

Ezaki Glico Co., Ltd

Division name

Institute of health science

Zip code

555-8502

Address

4-6-5 Utajima Nishiyodogawa-ku Osaka, 555-8502, Japan

TEL

0664778425

Email

takashi.mawatari@glico.com


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Mawatari

Organization

Ezaki Glico Co., Ltd

Division name

Institute of health sciences

Zip code

555-8502

Address

4-6-5 Utajima Nishiyodogawa-ku Osaka, 555-8502, Japan

TEL

0664778425

Homepage URL


Email

takashi.mawatari@glico.com


Sponsor or person

Institute

Ezaki Glico Co., Ltd

Institute

Department

Personal name



Funding Source

Organization

Ezaki Glico Co., Ltd

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Institutional Review Board of Glico Group

Address

2-4, Komatsubara-cho, Kita-ku, Osaka, Japan

Tel

+81-6-6477-8201

Email

ebisutani-kazuki@glico.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

63

Results

1. The intestinal microbiota is modulated.
2. The Faecalibacterium ratio, Bifidobacterium ratio and number, as well as the amount of short-chain fatty acid in feces increase.
3. The effect on intestinal microbiota varies depending on the number of ingested bacteria.

Results date posted

2019 Year 09 Month 06 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 09 Month 04 Day

Date of IRB

2017 Year 09 Month 04 Day

Anticipated trial start date

2017 Year 09 Month 11 Day

Last follow-up date

2017 Year 12 Month 08 Day

Date of closure to data entry

2019 Year 03 Month 04 Day

Date trial data considered complete

2019 Year 03 Month 06 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information

The group of interventions control 3 was excluded from analysis due to defect of the test drink.


Management information

Registered date

2017 Year 09 Month 11 Day

Last modified on

2019 Year 09 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033268